Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashvini Keshavan

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
The Lancet. Neurology|August 16, 2025
Plasma phosphorylated tau for Alzheimer's disease diagnosisAshvini Keshavan, Alicia Algeciras-Schimnich
Molecular Diagnosis & Therapy|October 15, 2016
Blood Biomarkers for Alzheimer's Disease: Much Promise, Cautious ProgressAshvini Keshavan, Amanda Heslegrave, Henrik Zetterberg, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 14, 2018
Stability of blood-based biomarkers of Alzheimer's disease over multiple freeze-thaw cyclesAshvini Keshavan, Amanda Heslegrave, Henrik Zetterberg, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersNatalia Chemas, Rifah Anjum, Charles R Marshall, et al.
Practical Neurology|July 29, 2021
Bilateral optic neuritis as a first presentation of lymph node tuberculosisAshvini Keshavan, Lisa McAnena, James F Acheson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersAshvini Keshavan, Katharine Wiltshire, Melanie Hart, et al.
Renal Failure|January 19, 2012
Fortuitous vasculitisHema Sharma, Ashvini Keshavan, Mark Alan Little, et al.
Age and Ageing|May 6, 2026
Factors influencing implementation of an Alzheimer's disease blood test among UK old age psychiatrists: mixed-methods study using the theoretical domains frameworkHazan Jemma, Mitchell Mealing, Fabiana Lorencatto, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 22, 2026
Aging-related matrix metallopeptidase 10 and osteopontin levels are associated with pathology, cognitive decline, and age at onset in Alzheimer's diseaseBryan Ng, Eleftheria Kodosaki, Elena Veleva, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 8, 2026
Perceptions of the use of biomarkers for Alzheimer's disease diagnosis: A systematic review and synthesis of the qualitative literatureJemma Hazan, Mitchell Mealing, Emma Mittelman, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
The Lancet. Neurology|August 16, 2025
Plasma phosphorylated tau for Alzheimer's disease diagnosisAshvini Keshavan, Alicia Algeciras-Schimnich
Molecular Diagnosis & Therapy|October 15, 2016
Blood Biomarkers for Alzheimer's Disease: Much Promise, Cautious ProgressAshvini Keshavan, Amanda Heslegrave, Henrik Zetterberg, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 14, 2018
Stability of blood-based biomarkers of Alzheimer's disease over multiple freeze-thaw cyclesAshvini Keshavan, Amanda Heslegrave, Henrik Zetterberg, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersNatalia Chemas, Rifah Anjum, Charles R Marshall, et al.
Practical Neurology|July 29, 2021
Bilateral optic neuritis as a first presentation of lymph node tuberculosisAshvini Keshavan, Lisa McAnena, James F Acheson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersAshvini Keshavan, Katharine Wiltshire, Melanie Hart, et al.
Renal Failure|January 19, 2012
Fortuitous vasculitisHema Sharma, Ashvini Keshavan, Mark Alan Little, et al.
Age and Ageing|May 6, 2026
Factors influencing implementation of an Alzheimer's disease blood test among UK old age psychiatrists: mixed-methods study using the theoretical domains frameworkHazan Jemma, Mitchell Mealing, Fabiana Lorencatto, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 22, 2026
Aging-related matrix metallopeptidase 10 and osteopontin levels are associated with pathology, cognitive decline, and age at onset in Alzheimer's diseaseBryan Ng, Eleftheria Kodosaki, Elena Veleva, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 8, 2026
Perceptions of the use of biomarkers for Alzheimer's disease diagnosis: A systematic review and synthesis of the qualitative literatureJemma Hazan, Mitchell Mealing, Emma Mittelman, et al.
Pageof 7